Samarkand Group plc is strategically pivoting towards enhancing its portfolio of owned health and wellness brands while restructuring its distribution operations to optimize growth potential.

Information on the Target

Samarkand Group plc, listed on AQSE under the ticker SMK, operates as a consumer brand owner and provides cross-border eCommerce distribution services. This innovative company focuses on creating and managing niche brands in the health and well-being sector, particularly those related to natural herbal health, beauty, and reproductive health. Spanning various consumer segments, Samarkand aims to develop unique products that meet the increasing demand for health-focused offerings.

In its interim results for the half year ending September 30, 2024 (H1 2025), the Group announced a strategic realignment towards expanding its portfolio of owned brands, including Napiers the Herbalists, Zita West, Nature’s Greatest Secret, and Benatural. This shift reflects a commitment to enhance brand ownership while simultaneously restructuring its distribution operations in China to streamline focus on a more select array of third-party brands.

Industry Overview in the Target’s Specific Country

The health and wellness industry in the UK is experiencing significant growth, propelled by a heightened consumer awareness of health issues and the demand for natural and organic products. Consumers

View Source

Similar Deals

Triple The Lawyer

2025

Other Advertising & Marketing (NEC) United Kingdom
WPP InfoSum

2025

Other Advertising & Marketing (NEC) United Kingdom
InteleTravel Tickitto

2025

Other Travel Agents United Kingdom
Powder Monkey Group Castle Eden Brewery

2025

Other Sportswear & Outdoors Clothing United Kingdom
GENDA Inc. Inspired Entertainment Inc. UK holiday parks business

2025

Other Gaming Machine Operators United Kingdom
Stoneweg InfraSport Emerge Surf

2025

Other Adventure Sports Facilities & Ski Resorts United Kingdom

Samarkand Group plc

invested in

Optimised Energetics Ltd

in 2024

in a Other deal

Disclosed details

Revenue: $8M

EBITDA: $-1M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert